March 6, 2021 – There have been many pretrial orders entered over the past few months in the Zantac/Ranitidine Multi-District Litigation (MDL) as referenced below. This list will continue to be amended as new orders are entered. The orders can also be found here: https://www.flsd.uscourts.gov/zantac. March 2021 March 5: Zantac Lawsuit MDL Pretrial Order # 61 – Order on...
Continue ReadingMarch 6, 2021 – The Court has still not ruled on the motion to dismiss made by big-name distributors such as Walgreens and Walmart, but we are watching for the ruling and will update when it comes. Reference: “United States District Court.” 20-MD-2924-Rosenberg – In Re: Zantac (Ranitidine) Products Liability Litigation | Southern District of Florida | United States...
Continue ReadingFebruary 17, 2021 – The United States Judicial Panel on Multidistrict Litigation reported at their panel that there were currently 562 cases pending in the Zantac Lawsuit MDL. Reference: “Zantac Lawsuit: February 2021 Update – Zantac Cancer Claims.” Drug Watch, www.drugwatch.com/zantac/lawsuits/.
Continue ReadingA court in Louisiana granted the defendant’s motion to dismiss two of three product defect claims in a lawsuit. Plaintiffs Stephanie and Robert Fuller accused the defendant, Eisai Inc. and Arena Pharmaceuticals Inc., of design defects, manufacturing defects, and safety misrepresentations related to its drug Belviq. The weight loss drug is allegedly linked to breast cancer, according to the...
Continue ReadingJanuary 19, 2021 — Veterans are increasingly filing Zantac lawsuits claiming the drug has caused cancer. The lawsuits allege that the manufacturers knew the active ingredient in Zantac, ranitidine could form a toxic chemical called N-Nitrosodimethylamine (NDMA) inside the human stomach, but kept this information from the public. NDMA is known to cause cancer in animals and may cause cancer in humans....
Continue ReadingWhen you lose a loved one due to someone else’s actions, you may experience many emotions. Naturally, you feel grief and anger. You may also wonder how you can achieve justice for your loved one and prevent others from experiencing similar harm. At Gerling Law, we can’t take away your pain. However, we can help you pursue justice. We...
Continue ReadingJanuary 11, 2021 – Federal MDL Judge Rosenberg of the U.S. District Court for the Southern District of Florida ruled that design defect claims filed against the manufacturers of Zantac (ranitidine) are preempted by federal law because they seek to challenge the drugs’ FDA approved formula. The judge granted the motion by Sanofi, GlaxoSmithKline, Pfizer Inc and Boehringer Ingelheim to...
Continue ReadingJuly 2021 — The second trial for Group B is scheduled to begin around July 2021. May 2021 — The first trial in the Group B Bellwether Trial is scheduled to begin around May 2021. March 2021 — The third trial for Group A is scheduled to begin around March. Additionally, the court is scheduled to select two cases...
Continue ReadingDecember 21, 2020 — The Court continued the second bellwether trial. Reference: “United States District Court.” MDL – 2740 Taxotere (Docetaxel) Products Liability Litigation | Eastern District of Louisiana | United States District Court, 28 Dec. 2020, www.laed.uscourts.gov/case-information/mdl-mass-class-action/taxotere
Continue ReadingDecember 23, 2020 — Judge Harvey Bartle ruled that all but part of one of the 22 documents in dispute were not shielded by the attorney-client privilege. Accordingly, Merck & Co. is required to disclose internal emails about potential changes to the label of Zostavax, which could reveal its knowledge of the adverse effects its vaccine was causing long...
Continue Reading